Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: A cohort study

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Russell, Elizabeth C ^a   Charalambous, Salome ^b   Pemba, Lindiwe ^b   Churchyard, Gavin J ^a,b   Grant, Alison D ^a   Fielding, Katherine ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b AURUM INSTITUTE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SOUTH AFRICA; SURVIVAL;

ADOLESCENT; ADULT; AGED; ANTIRHEUMATIC AGENTS; COHORT STUDIES; FEMALE; HEMOGLOBINS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SOUTH AFRICA; SURVIVAL ANALYSIS;

EID: 77954778198     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-433     Document Type: Article

References (29)

1. UNAIDS/WHO, Epidemiological Fact Sheets on HIV and AIDS, 2008 update WHO 2008
2. UNAIDS, 2008 Report in the global AIDS epidemic UNAIDS 2008
3. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. D Coetzee K Hildebrand A Boulle G Maartens F Louis V Labatala H Reuter N Ntwana E Goemaere, AIDS 2004 18 887 895 10.1097/00002030- 200404090-00006 15060436
4. Progress Report on Declaration of Commitment on HIV and AIDS - South Africa. UNGASS, 2007 28
5. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. SD Lawn L Myer C Orrell LG Bekker R Wood, AIDS 2005 19 2141 2148 10.1097/01.aids.0000194802. 89540.e1 16284464
6. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. JF Etard I Ndiaye M Thierry-Mieg NF Gueye PM Gueye I Laniece AB Dieng A Diouf C Laurent S Mboup PS Sow E Delaporte, AIDS 2006 20 1181 1189 10.1097/01.aids.0000226959.87471.01 16691070
7. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. L Ferradini A Jeannin L Pinoges J Izopet D Odhiambo L Mankhambo G Karungi E Szumilin S Balandine G Fedida MP Carrieri B Spire N Ford JM Tassie PJ Guerin C Brasher, Lancet 2006 367 1335 1342 10.1016/S0140-6736(06)68580-2 16631912
8. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. PJ Weidle S Malamba R Mwebaze C Sozi G Rukundo R Downing D Hanson D Ochola P Mugyenyi J Mermin B Samb E Lackritz, Lancet 2002 360 34 40 10.1016/S0140-6736(02)09330-3 12114039
9. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. P Braitstein MW Brinkhof F Dabis M Schechter A Boulle P Miotti R Wood C Laurent E Sprinz C Seyler DR Bangsberg E Balestre JA Sterne M May M Egger, Lancet 2006 367 817 824 10.1016/S0140-6736(06)68337-2 16530575
10. Establishing a workplace antiretroviral therapy programme in South Africa. S Charalambous AD Grant JH Day L Pemba RE Chaisson P Kruger D Martin R Wood B Brink GJ Churchyard, AIDS Care 2007 19 34 41 10.1080/09500340600677872 17129856 (Pubitemid 44852408)
11. WHO, Iron Deficiency Anaemia. Assessment, Prevention and Control: A Guide for programme managers WHO 2001
12. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d'Ivoire: 2-year outcomes and determinants. S Toure B Kouadio C Seyler M Traore N Dakoury-Dogbo J Duvignac N Diakite S Karcher C Grundmann R Marlink F Dabis X Anglaret, AIDS 2008 22 873 882 10.1097/QAD.0b013e3282f768f8 18427206
13. Multiple Imputation of missing values. P Royston, Stata Journal 2004 4 227 241
14. DB Rubin, Multiple Imputation for nonresponse in surveys New York: John Wiley 1987
15. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. K Wools-Kaloustian S Kimaiyo L Diero A Siika J Sidle CT Yiannoutsos B Musick R Einterz KH Fife WM Tierney, AIDS 2006 20 41 48 10.1097/01.aids.0000196177.65551.ea 16327318
16. Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. CW Wester S Kim H Bussmann A Avalos N Ndwapi TF Peter T Gaolathe A Mujugira L Busang C Vanderwarker P Cardiello O Johnson I Thior P Mazonde H Moffat M Essex R Marlink, J Acquir Immune Defic Syndr 2005 40 336 343 10.1097/01.qai.0000159668. 80207.5b 16249709
17. Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. BO Ojikutu H Zheng RP Walensky Z Lu E Losina J Giddy KA Freedberg, S Afr Med J 2008 98 204 208 18350223
18. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JS Stringer I Zulu J Levy EM Stringer A Mwango BH Chi V Mtonga S Reid RA Cantrell M Bulterys MS Saag RG Marlink A Mwinga TV Ellerbrock M Sinkala, JAMA 2006 296 782 793 10.1001/jama.296.7.782 16905784
19. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. SD Lawn AD Harries X Anglaret L Myer R Wood, AIDS 2008 22 1897 1908 10.1097/QAD.0b013e32830007cd 18784453
20. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. A Johannessen E Naman BJ Ngowi L Sandvik MI Matee HE Aglen SG Gundersen JN Bruun, BMC Infect Dis 2008 8 52 10.1186/1471-2334-8-52 18430196
21. Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. RJ Harris JA Sterne S Abgrall F Dabis P Reiss M Saag AN Phillips G Chene JM Gill AC Justice J Rockstroh CA Sabin A Mocroft HC Bucher RS Hogg AD Monforte M May M Egger, Antivir Ther 2008 13 959 967 19195321
22. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa. R Moh C Danel E Messou T Ouassa D Gabillard A Anzian Y Abo R Salamon E Bissagnene C Seyler X Anglaret, AIDS 2007 21 2483 2491 10.1097/QAD.0b013e3282f09876 18025885
23. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa. RP Dalal C Macphail M Mqhayi J Wing C Feldman MF Chersich WD Venter, J Acquir Immune Defic Syndr 2008 47 101 107 10.1097/QAI.0b013e31815b833a 17971708
24. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. S Rosen MP Fox CJ Gill, PLoS Med 2007 4 298 10.1371/journal.pmed.0040298 17941716
25. Overestimates of survival after HAART: implications for global scale-up efforts. GP Bisson T Gaolathe R Gross C Rollins S Bellamy M Mogorosi A Avalos H Friedman D Dickinson I Frank N Ndwapi, PLoS One 2008 3 1725 10.1371/journal. pone.0001725 18320045
26. Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. CT Yiannoutsos MW An CE Frangakis BS Musick P Braitstein K Wools-Kaloustian D Ochieng JN Martin MC Bacon V Ochieng S Kimaiyo, PLoS One 2008 3 3843 10.1371/journal.pone.0003843 19048109
27. Mortality and loss to follow-up among HAART initiators in rural South Africa. P Macpherson M Moshabela N Martinson P Pronyk, Trans R Soc Trop Med Hyg 2009 103 588 93 10.1016/j.trstmh.2008.10.001 19012940
28. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. SD Lawn L Myer D Edwards LG Bekker R Wood, AIDS 2009 23 1717 1725 10.1097/QAD.0b013e32832d3b6d 19461502
29. Causes of mortality in patients on antiretroviral therapy in South Africa. CS Innes L Pemba M Bogoshi J Whetham S Senoge P Seatlanyane K Fielding GJ Churchyard AD Grant, 3rd South African AIDS Conference [abstract 698] (oral presentation) 2007